SCR'21 - Update on malignant mesothelioma: Pathogenesis, diagnostic evaluation, staging and therapeutic concepts
Veranstaltungsdetails
SCR’21 Online Edition Webinar 5 Joint plenary session SGR-SSR/SGNM-SSMN Update on malignant mesothelioma: Pathogenesis, diagnostic evaluation, staging and therapeutic concepts Moderators: J. Prior, Lausanne/CH; B. Halpern, Münsterlingen/CH Update on malignant mesothelioma:
Veranstaltungsdetails
SCR’21 Online Edition Webinar 5
Joint plenary session SGR-SSR/SGNM-SSMN
Update on malignant mesothelioma: Pathogenesis, diagnostic evaluation, staging and therapeutic concepts
Moderators: J. Prior, Lausanne/CH; B. Halpern, Münsterlingen/CH
Update on malignant mesothelioma: Pathogenesis and diagnostic evaluation
Speaker: L. R. Chirieac, Harvard/US
Learning objectives:
– To present recently described genomic and pathogenetic alterations in mesothelioma
– To describe current immunohistochemical antibodies with diagnostic importance in mesothelioma
Diagnostic evaluation and staging – Significant imaging concepts
Speaker: R. R. Gill, Harvard/US
Learning objectives:
– To review the role of multimodality imaging in evaluation of Malignant Pleural Mesothelioma
– To illustrate how quantitative imaging techniques play a role in staging and management of Mesothelioma
New European treatment guidelines for MPM
Speaker: I. Opitz, Zurich/CH
Learning objectives:
– To learn the recommendations from recent European Guidelines about MPM treatment
– To learn the recommendations from recent European Guidelines about Diagnosis of MpM
This session is accredited with 1 SGR-SSR CME credit (Category 1), 1 SGNM-SSMN CME credit (Formation continue essentielle spécifique/Fachspezifische Kernfortbildung) and 1 SVMTR-ASTRM log-point.
Zeit
Ort
online only
